FDA Inspection
Gulbrandsen Technologies IncGulbrandsen Technologies Inc – FDA Inspection, Feb 16, 2022
Record Details
This FDA Inspection record concerns Gulbrandsen Technologies Inc, with an inspection on February 16, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Gulbrandsen Technologies Inc
- Inspection Date
- February 16, 2022
- Product Type
- Drugs
View Company Profile
ID · c66a2f54-57a9-4965-9968-d792d5880f34
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1162450
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Gulbrandsen Technologies Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Gulbrandsen Technologies Inc
- FDA Inspection 940151 - 2015-08-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.